0001562180-17-000880.txt : 20170223 0001562180-17-000880.hdr.sgml : 20170223 20170223160216 ACCESSION NUMBER: 0001562180-17-000880 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170221 FILED AS OF DATE: 20170223 DATE AS OF CHANGE: 20170223 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Akebia Therapeutics, Inc. CENTRAL INDEX KEY: 0001517022 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 208756903 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 245 FIRST STREET STREET 2: SUITE 1100 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-871-2098 MAIL ADDRESS: STREET 1: 245 FIRST STREET STREET 2: SUITE 1100 CITY: CAMBRIDGE STATE: MA ZIP: 02142 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hadas Nicole R. CENTRAL INDEX KEY: 0001602396 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36352 FILM NUMBER: 17632407 MAIL ADDRESS: STREET 1: 20 PILGRAM DRIVE CITY: WINCHESTER STATE: MA ZIP: 01890 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2017-02-21 false 0001517022 Akebia Therapeutics, Inc. AKBA 0001602396 Hadas Nicole R. C/O AKEBIA THERAPEUTICS, INC. 245 FIRST STREET CAMBRIDGE MA 02142 false true false false SVP, General Counsel, Sec. Common Stock 2017-02-21 4 A false 28500.00 0.00 A 111412.00 D Stock Option (Right to buy) 0.00 2017-02-21 4 A false 45000.00 10.14 A 2027-02-21 Common Stock 45000.00 45000.00 D The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan. One hundred percent of the restricted stock units will vest on the third anniversary of the grant date. 25% of the shares underlying this option will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter. John P. Butler, Attorney-in-Fact for Nicole R. Hadas 2017-02-23